Annual accounts
Small accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
GREY WOLF THERAPEUTICS LIMITED
Active- 10989365Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 99 Park Drive, Milton, Abingdon OX14 4RY
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 20/08/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2026-06-29
- 05/08/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2026-06-21
- 29/07/2026View PDF (1 pages)
Resolutions
- 11/03/2026View PDF (1 pages)
Resolutions
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 27/10/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures GREY WOLF THERAPEUTICS LIMITED filed. Okredo holds filed accounts data for 2022–2024; the year-by-year record is on the financials page.
Net Assets
£26.29M2024
129.58%vs 20232023: £11.45M
Total Assets
£28.96M2024
83.87%vs 20232023: £15.75M
Cash in Bank
£20.42M2024
126.07%vs 20232023: £9.03M
Total Liabilities
£2.61M2024
-38.44%vs 20232023: £4.24M
Employees
192024
+1vs 20232023: 18
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Net assets moved furthest, up 129.58% on 2023. See the full financial analysis for GREY WOLF THERAPEUTICS LIMITED.
The full financial record
Four ways through GREY WOLF THERAPEUTICS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +61.1% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2022–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 19 | +1 |
| 2023 | 18 | +4 |
| 2022 | 14 | – |
Reported employee count increased from 14 in 2022 to 19 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
16Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/09/2017–Present | 2 | |
| Director | 29/03/2018–Present | 0 | |
| Director | 02/03/2026–Present | 1 | |
| Director | 29/09/2017–Present | 11 | |
| Director | 18/03/2018–29/03/2018 | 6 | |
| Director | 16/04/2026–Present | 20 | |
| Secretary | 22/06/2022–01/03/2025 | 0 | |
| Director | 29/03/2018–Present | 2 | |
| Director | 29/03/2018–Present | 3 | |
| Director | 25/11/2024–Present | 4 | |
| Director | 23/12/2022–25/11/2024 | 2 | |
| Director | 23/12/2022–10/12/2025 | 8 | |
| Director | 23/12/2022–Present | 0 | |
| Director | 23/12/2022–Present | 1 | |
| Director | 15/05/2024–02/03/2026 | 0 | |
| Secretary | 01/05/2025–Present | 0 |
Persons with significant control
4Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 29/09/2017–29/03/2018 | 2 | |
| 12/02/2019–12/02/2019 | 0 | |
| 12/02/2019–12/02/2019 | 0 | |
| 29/09/2017–29/03/2018 | 11 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 52 Since 18/10/2018
- Last 12 months
- 17 +8 vs the year before
- Most recent filing
- 20/08/2026 1 month ago
What changed in the last year
- Share capital (7)Latest 20/08/2026
- Officer changes (3)Latest 06/03/2026
- Confirmation statementLatest 13/02/2026
- Accounts filedLatest 15/12/2025
Filing timeline
- 20/08/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2026-06-29
- 05/08/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2026-06-21
- 29/07/2026View PDF (1 pages)
Resolutions
- 11/03/2026View PDF (1 pages)
Resolutions
- 11/03/2026View PDF (63 pages)
Memorandum and Articles of Association
- 06/03/2026View PDF (2 pages)
Appointment of Allan Marchington as a director on 2026-03-02
- 04/03/2026View PDF (1 pages)
Termination of appointment of Tracy Weightman as a director on 2026-03-02
- 13/02/2026View PDF (12 pages)
Confirmation statement made on 2025-10-27 with updates
- 28/01/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2025-12-24
- 19/01/2026View PDF (6 pages)
Replacement filing of SH01 - 02/06/25 Statement of Capital gbp 2987.4578
- 14/01/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2025-05-29
- 14/01/2026View PDF (5 pages)
Statement of capital following an allotment of shares on 2025-08-06
Showing 12 of 52 filings
See when the next accounts and confirmation statement are due
Similar companies
45 UK companies are similar to GREY WOLF THERAPEUTICS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
SOLIVUS LIMITED
Active5th Floor Sustainable Ventures, County Hall, Westminster Bridge Road, London SE1 7PB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 10076849
- Incorporated
- 22/03/2016
- Employees
- 18
FIBROFIND LTD
ActiveUnit 26-27, The Pantry Bakers Yard, Christon Road, Newcastle Upon Tyne NE3 1XD
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11694429
- Incorporated
- 23/11/2018
- Employees
- 16
52 NORTH HEALTH LTD
ActiveKetton Suite The King Centre, Main Road, Barleythorpe, Oakham LE15 7WD
- Activity
- Research and experimental development on biotechnology
- Company no.
- 11460425
- Incorporated
- 11/07/2018
- Employees
- 18
LEVISTOR LTD
Active2 Old Court Mews, 311a Chase Road, London N14 6JS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 13216670
- Incorporated
- 22/02/2021
- Employees
- 15
ANTIVERSE LTD
ActiveSbarc, Spark 5th Floor, Maindy Rd, Cardiff CF24 4HQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10736975
- Incorporated
- 24/04/2017
- Employees
- 15
About GREY WOLF THERAPEUTICS LIMITED
A short description of the company, written from its Companies House record.
GREY WOLF THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, based in 99 Park Drive, Milton, Abingdon OX14 4RY. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 8 years 11 months.
The register currently records it as active. Its 2024 accounts report net assets of £26.29M and 19 employees.
GREY WOLF THERAPEUTICS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does GREY WOLF THERAPEUTICS LIMITED do?
Companies House records GREY WOLF THERAPEUTICS LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is GREY WOLF THERAPEUTICS LIMITED still active?
GREY WOLF THERAPEUTICS LIMITED is recorded as active on the Companies House register, and has been on it since 29/09/2017.
What are GREY WOLF THERAPEUTICS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £26.29M, total assets of £28.96M, cash in bank of £20.42M and total liabilities of £2.61M.
When did GREY WOLF THERAPEUTICS LIMITED last file with Companies House?
The most recent document on the record is dated 20/08/2026: Statement of capital following an allotment of shares on 2026-06-29, 1 month ago.
When are GREY WOLF THERAPEUTICS LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs GREY WOLF THERAPEUTICS LIMITED?
Companies House lists 16 officers (11 currently in post) and 4 people with significant control (0 current).